Osso e infiammazione

Besdine RW, Wetle TF (2010) Improving health for elderly people: an international health promotion and disease prevention agenda. Aging Clin Exp Res 22:219–230 NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795 Seeman E (2003) Bone quality. Osteoporos Int 14(S5):3–7 Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137 Manolagas SC, Jilka RL (1995) Mechanism of disease: bone marrow, cytokines, and bone remodeling—emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332(5):305–311 Kimble RB, Matayoshi AB, Vannice JL et al. (1995) Simultaneous block of intereleukin 1 and tumor necrosis factor is required to completely prevent bone loss in the early post-ovariectomy period. Endocrinology 136(7):3054–3061 Weitzmann MN (2013) The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in the physiological bone turnover and osteoporosis. Scientifica 2013:1–29 Lee SK, Kalinowski JF, Jastrzebski SL et al. (2003) Interleukin 7 is a direct inhibitor of in vitro osteoclastogenesis. Endocrinology 144(8):3524–3531 Takayanagi H, Ogasawara K, Hida S et al. (2000) T-cell mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and INF-γ. Nature 408(6812):600–605 Weitzmann MN, Cenci S, Haug J et al. (2001) B lymphocytes inhibit human osteoclastogenesis by secretion of TGF-β. J Bone Miner Res 273(42):27091–27096 Greco EA, Francomano D, Fornari R et al. (2013) Negative association between trunk fat, insulin resistance and skeleton in obese women. World J Diabetes 4(2):31–39 Wannenes F, Papa V, Greco EA et al. (2014) Abdominal fat and sarcopenia in women significantly alter osteoblast homeostasis in vitro by a WNT/β-catenin dependent mechanism. Internet J Endocrinol. doi:10.1155/2014/278316